The Trump administration pulled the plug on IRS Direct File, a pilot program allowing taxpayers to file federal tax returns for free. But there are still many no-cost filing options available, ...

Rachel is a freelancer based in Echo Park, Los Angeles and has been writing and producing content for nearly two decades on subjects ranging from tech to fashion, health and lifestyle to entertainment ...

GOLD CORP. (TSX: IAU) (NYSE American: IAUX) ("i-80 Gold" or the "Company") reports its operating and financial results, as ...

Law school is thought to be the last step before legal practice. Pupils take years to learn laws, decisions and legal ...

GOLD CORP. (TSX: IAU) (NYSE American: IAUX) ("i-80 Gold" or the "Company") is pleased to announce that it has secured a financing package (the "Financing Package") of up to $500 million, comprised of ...

Dave Ramsey warns nearly 50% of Americans are making 1 big Social Security mistake — here’s what it is and 3 simple steps to fix it ASAP Approaching retirement with no savings? Don’t panic, you're not ...

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the ...

With more than a decade of experience, Nelson covers Apple and Google and writes about iPhone and Android features, privacy and security settings, and more. AI is the ultimate "work smarter" shortcut ...

India’s climate diplomacy—selectively engaging with UN Framework Convention on Climate Change processes while separately mobilizing finance, technology, and market access for decarbonization without ...

While renewables have received scrutiny from the Trump administration and congressional Republicans over subsidies, the administration’s narrative hides how fossil fuel industries reap the benefits of ...

At 36 weeks in the TOGETHER-PsO study, concomitant Taltz and Zepbound met primary endpoint of superiority vs. Taltz monotherapy in achieving complete skin clearance ...

Eli Lilly and Company today announced positive topline results from the landmark TOGETHER-PsO open-label Phase 3b clinical trial evaluating the concomitant use of Taltz (ixekizumab) and Zepbound ...